Multi-omics survival prediction under modality incompleteness via dynamic modality graphs and product-of-experts fusion

Clicks: 3
ID: 338169
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #60 of 62 articles by views in Briefings in bioinformatics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Multi-omics data integration provides rich complementary information for cancer survival prediction, yet modality incompleteness is pervasive in real-world medical data and undermines the stability and applicability of existing models. To address this challenge, we propose DMG-PoE, a robust learning framework for multi-omics survival prediction. The framework introduces a dynamic modality graph (DMG) that propagates complementary information across modality nodes to compensate for missing inputs, combined with an uncertainty-aware product-of-experts (PoE) fusion mechanism that adaptively weights each modality by its estimated precision, and a consistency-constrained training strategy that stabilizes predictions across varying modality subsets. Systematic evaluation on the SurvBoard benchmark across 10 TCGA cancer types and seven omics modalities demonstrates that DMG-PoE achieves the highest average C-index under both the standard setting (complete-modality training/testing) and the missing-augmented setting (training additionally includes real incomplete samples and nonclinical modality dropout, with complete-only testing); controlled per-modality masking experiments validate effective test-time recovery in 22/24 cancer-modality combinations, and cross-cohort transfer with only two of seven modalities available further confirms generalization under severe input restriction.
Reference Key
openalex_W7225090782 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Briefings in bioinformatics
Year 2026
DOI
10.1093/bib/bbag596
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.